Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies. The firm manages approximately $1.8 billion in assets and has a track record of investing and returning capital since 2000.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions